![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg\"){kind=logo}
<\/p>\n<\/p>\n
According to the new market research report\u00a0\u201c<\/strong>Infectious Disease Diagnostics Market<\/a>\u00a0by Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza), End User \u2013 Global Forecast to 2026\u2033,<\/strong>\u00a0published by MarketsandMarkets Browse in-depth TOC on\u00a0<\/em>\u201cInfectious Disease Diagnostics Market\u201d<\/p>\n 147 \u2013 Tables <\/strong>Download PDF Brochure:\u00a0<\/strong> The global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements are factors supporting the growth of this market. Growth opportunities in growing economies provide lucrative opportunities for the players operating in the market.<\/p>\n The reagents, kits, and consumables segment accounted for the largest share of the market, by product & service segment, in 2020<\/p>\n <\/strong>Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.<\/p>\n POC testing segment to register the highest CAGR during the forecast period<\/p>\n <\/strong>Based on the type of testing, the market has been segmented into laboratory testing and POC testing. In 2020, the POC testing segment accounted for the highest CAGR. This can be attributed to the need to closely monitor patient conditions and advantages such as faster diagnosis.<\/p>\n The COVID-19 segment accounted for the largest share of the infectious disease diagnostics market, by disease type segment, in 2020<\/strong><\/p>\n Based on disease type, the market is segmented into COVID-19, HIV, HAIs, hepatitis, CT\/NG, HPV, TB, influenza, and other infectious diseases. In 2020, the COVID-19 disease type segment accounted for the largest share of this market. Factors such as the increasing number of cases and the availability of many COVID-19 diagnostic tests are driving the growth of this market.<\/p>\n The diagnostic laboratories segment accounted for the largest share of the infectious disease diagnostics market, by end user segment, in 2020<\/p>\n <\/strong>Based on end user, the market has been segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. In 2020, diagnostic laboratories accounted for the largest share of the market. Diagnostic laboratories command the major share of the market owing to increased test volume of infectious diseases and strengthening healthcare infrastructure for efficient disease diagnosis and treatment.<\/p>\n Request Sample Pages:<\/strong> North America<\/span>\u00a0is the largest regional market for infectious disease diagnostics market<\/p>\n <\/strong>The infectious disease diagnostic market is segmented into five regions, namely,\u00a0North America<\/span>,\u00a0Europe<\/span>,\u00a0Asia Pacific<\/span>,\u00a0Latin America<\/span>, and the\u00a0Middle East<\/span>\u00a0&\u00a0Africa<\/span>. In 2020,\u00a0North America<\/span>\u00a0accounted for the largest share of the market. The large share of this region can be attributed to the highly developed healthcare system in the US and\u00a0Canada<\/span>, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.<\/p>\n The major players operating in this infectious disease diagnostics market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland<\/span>), bioM\u00e9rieux SA (France<\/span>), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany<\/span>), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands<\/span>), Grifols S.A. (Spain<\/span>), DiaSorin S.p.A (Italy<\/span>), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan<\/span>), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia<\/span>), OraSure Technologies (US), Trinity Biotech Plc. (Ireland<\/span>), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea<\/span>), Co-Diagnostics, Inc. (US), ELITechGroup (France<\/span>), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India<\/span>), Meril Life Sciences Pvt. Ltd. (India<\/span>), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland<\/span>).<\/p>\n Mr. Ashish Mehra The post Infectious Disease Diagnostics Market worth $39.8 billion by 2026<\/a> appeared first on Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" According to the new market research report “Infectious Disease Diagnostics Market by Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza), End User – Global Forecast to 2026″, published by MarketsandMarkets™, the market is projected to reach USD 39.8 billion by 2026 from USD 28.1 billion in 2021, at a 7.2% CAGR. […]<\/p>\n The post Infectious Disease Diagnostics Market worth $39.8 billion by 2026<\/a> appeared first on Financial Market Brief<\/a>.<\/p>\n![\"\u2122\"](\"https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/72x72\/2122.png\")
, the market is projected to reach\u00a0USD 39.8 billion<\/span>\u00a0by 2026 from\u00a0USD 28.1 billion<\/span>\u00a0in 2021, at a 7.2% CAGR.<\/p>\n
45 \u2013 Figures
263 \u2013 Pages<\/p>\n
https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=116764589<\/a><\/p>\n
https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=116764589<\/a><\/p>\n\nContact Information:<\/h3>\n
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441<\/p>\n<\/p>\n<\/div>\n